Buprenorphine Study in JAMA
Millennium Health Publication in JAMA Network Open Highlights Drug Use Trends in Patients Treated with Buprenorphine for Opioid Use Disorder
SAN DIEGO, Calif. – September 14, 2021 – A JAMA Network Open study, led by Brendan Saloner, PhD, Associate Professor with Johns Hopkins Bloomberg School of Public Health, and co-authored by Millennium Health researchers, highlights the role of buprenorphine as a critically important medication for reducing harmful opioid use.